Pre-and post-transfusion testing for hepatitis b virus surface antigen and antibody in blood recipients: A single-institution experience in an area of high endemicity

Annals of Laboratory Medicine

Volumn 32, Issue 1, 2012, Pages 73-78

  Kim, Hyeongsu ^a   Hur, Mina ^a   Moon, Hee Won ^a   Park, Chul Min ^a   Cho, Jin Hee ^a   Park, Kyoung Sik ^a   Lee, Kunsei ^a   Chang, Sounghoon ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Hepatitis B virus; Recipients; Test; Transfusion; Transmission

Indexed keywords

EID: 84859613464     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2012.32.1.73     Document Type: Review

References (17)

1. Candotti D and Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009;51:798-809.
2. Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 2003;41:135-43. (Pubitemid 36098566)
3. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005;32:102-12. (Pubitemid 40093960)
4. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007;47:1162-71. (Pubitemid 46934305)
5. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004;44:1332-9. (Pubitemid 39129246)
6. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009;49:1115-25.
7. Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009; 52:57-62.
8. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion 2011;51:1840-6.
9. Llewelyn CA, Wells AW, Amin M, Casbard A, Johnson AJ, Ballard S, et al. The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies. Transfus Med 2009;19:89-98.
10. Wendel S, Levi JE, Biagini S, Candotti D, Allain JP. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion 2008;48:1602-8.
11. Iudicone P, Miceli M, Palange M, Agresti A, Gallo A, Isacchi G, et al. Hepatitis B virus blood screening: impact of nucleic amplification technology testing implementation on identifying hepatitis B surface antigen non-reactive window period and chronic infections. Vox Sang 2009;96: 292-7.
12. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vambakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007;47:316-25. (Pubitemid 46150983)
13. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-25. (Pubitemid 44289094)
14. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 2006;44:39-46.
15. Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003;38: 86-95. (Pubitemid 36775799)
16. Liang R. How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies of undergoing hematopoietic stem cell transplantation. Blood 2009;113:3147-53.
17. Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, et al. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood donation. Transfusion 2006;46:2028-9. (Pubitemid 44631612)